Jonathan Gill

4.5k total citations · 3 hit papers
84 papers, 3.0k citations indexed

About

Jonathan Gill is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Jonathan Gill has authored 84 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 36 papers in Oncology and 17 papers in Surgery. Recurrent topics in Jonathan Gill's work include Sarcoma Diagnosis and Treatment (33 papers), Neuroblastoma Research and Treatments (15 papers) and CAR-T cell therapy research (11 papers). Jonathan Gill is often cited by papers focused on Sarcoma Diagnosis and Treatment (33 papers), Neuroblastoma Research and Treatments (15 papers) and CAR-T cell therapy research (11 papers). Jonathan Gill collaborates with scholars based in United States, United Kingdom and China. Jonathan Gill's co-authors include Richard Görlick, David S. Geller, Douglas J. Harrison, Valerae O. Lewis, Michael Roth, Sajida Piperdi, Katherine A. Janeway, T. Christiansen, J. Andrew Livingston and Kenneth R. Evans and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Jonathan Gill

81 papers receiving 3.0k citations

Hit Papers

Advancing therapy for osteosarcoma 2017 2026 2020 2023 2021 2017 2022 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Advancing therapy for osteosarcoma
    2021 559 citations Jonathan Gill, Richard Görlick profile →
  2. Current and future therapeutic approaches for osteosarcoma
    2017 539 citations Douglas J. Harrison, David S. Geller et al. profile →
  3. Osteosarcoma
    2022 337 citations Hannah C. Beird, Stefan Bielack et al. Nature Reviews Disease Primers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Gill United States 21 1.4k 978 957 824 451 84 3.0k
Laura Mercatali Italy 29 1.7k 1.2× 768 0.8× 1.8k 1.9× 1.2k 1.5× 294 0.7× 108 3.7k
Heribert Juergens Germany 26 1.0k 0.8× 1.6k 1.6× 1.1k 1.1× 593 0.7× 531 1.2× 60 3.3k
François Lamoureux France 31 1.6k 1.1× 717 0.7× 830 0.9× 567 0.7× 216 0.5× 73 2.5k
Benjamin Ory France 29 1.4k 1.0× 611 0.6× 1.0k 1.1× 709 0.9× 215 0.5× 60 2.5k
Alexander J. Chou United States 25 931 0.7× 1.1k 1.1× 726 0.8× 503 0.6× 223 0.5× 61 2.4k
Zhenfeng Duan United States 37 1.7k 1.2× 996 1.0× 1.3k 1.4× 952 1.2× 440 1.0× 92 3.6k
Emiliano Cocco United States 32 1.1k 0.8× 833 0.9× 1.6k 1.6× 532 0.6× 294 0.7× 83 3.2k
Yuri Sheinin United States 29 1.2k 0.8× 867 0.9× 1.1k 1.2× 453 0.5× 576 1.3× 60 2.9k
Michael S. Isakoff United States 17 948 0.7× 718 0.7× 583 0.6× 530 0.6× 175 0.4× 35 2.2k
J.C. Soria France 21 1.0k 0.7× 980 1.0× 1.4k 1.4× 528 0.6× 529 1.2× 124 2.8k

Countries citing papers authored by Jonathan Gill

Since Specialization
Citations

This map shows the geographic impact of Jonathan Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Gill more than expected).

Fields of papers citing papers by Jonathan Gill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Gill. The network helps show where Jonathan Gill may publish in the future.

Co-authorship network of co-authors of Jonathan Gill

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Gill. A scholar is included among the top collaborators of Jonathan Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Gill. Jonathan Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gill, Jonathan, et al.. (2025). The Role of Sociodemographics in Pediatric, Adolescent and Young Adult Osteosarcoma: A Population Based Study. Journal of Pediatric Surgery. 60(4). 162202–162202.
2.
Rogers, Zoe, Adam Glaser, James W.F. Catto, et al.. (2023). Health‐related quality of life after a diagnosis of bladder cancer: a longitudinal survey over the first year. British Journal of Urology. 133(4). 460–473. 7 indexed citations
3.
Hingorani, Pooja, Wendong Zhang, Zhaohui Xu, et al.. (2022). Trastuzumab Deruxtecan, Antibody–Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing Consortium. Molecular Cancer Therapeutics. 21(8). 1318–1325. 12 indexed citations
4.
Beird, Hannah C., Stefan Bielack, Adrienne M. Flanagan, et al.. (2022). Osteosarcoma. Nature Reviews Disease Primers. 8(1). 77–77. 337 indexed citations breakdown →
5.
Beird, Hannah C., Stefan Bielack, Adrienne M. Flanagan, et al.. (2022). Author Correction: Osteosarcoma. Nature Reviews Disease Primers. 8(1). 82–82. 7 indexed citations
6.
Hingorani, Pooja, Michael Roth, Wendong Zhang, et al.. (2020). ABBV-085, Antibody–Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing Consortium. Molecular Cancer Therapeutics. 20(3). 535–540. 23 indexed citations
7.
Cuglievan, Branko, Amy M. Berkman, Seyedeh Dibaj, et al.. (2020). Impact of Lagtime, Health Insurance Type, and Income Status at Diagnosis on the Long-Term Survival of Adolescent and Young Adult Cancer Patients. Journal of Adolescent and Young Adult Oncology. 10(2). 164–174. 18 indexed citations
8.
Gill, Jonathan, Pooja Hingorani, Michael Roth, & Richard Görlick. (2020). HER2-Targeted Therapy in Osteosarcoma. Advances in experimental medicine and biology. 1257. 55–66. 9 indexed citations
9.
Hingorani, Pooja, Wendong Zhang, Raushan T. Kurmasheva, et al.. (2020). Abstract LB-217: Preclinical evaluation of trastuzumab deruxtecan (T-DXd; DS-8201a), a HER2 antibody-drug conjugate, in pediatric solid tumors by the Pediatric Preclinical Testing Consortium (PPTC). Cancer Research. 80(16_Supplement). LB–217. 5 indexed citations
10.
Gill, Jonathan, et al.. (2020). Urethral catheter trapped in the ureter removed using holmium laser: An unusual case and review of the literature. Journal of Clinical Urology. 16(1). 58–62. 1 indexed citations
11.
Bailey, Kayleen, Michael Roth, Daniel A. Weiser, & Jonathan Gill. (2018). High-Dose Chemotherapy with Stem Cell Rescue in Desmoplastic Small Round Cell Tumor: A Single-Institution Experience and Review of the Literature. Sarcoma. 2018. 1–10. 5 indexed citations
12.
13.
Ferrari, Andrea, Patrizia Gasparini, Jonathan Gill, & Richard Görlick. (2018). Challenges of Clinical Management of Adolescent and Young Adults With Bone and Soft Tissue Sarcoma. The Cancer Journal. 24(6). 301–306. 14 indexed citations
14.
15.
Yang, Yi, Rui Yang, Michael Roth, et al.. (2017). Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma model. Genes & Cancer. 8(1-2). 484–494. 27 indexed citations
16.
Olson, Kristofor A., Michael Roth, David S. Geller, et al.. (2017). Provider views on the management of Ewing sarcoma of the spine and pelvis. Journal of Surgical Oncology. 117(3). 417–424. 12 indexed citations
17.
Geller, David S., Wendong Zhang, Jonathan Gill, et al.. (2014). Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2. Clinical Cancer Research. 21(13). 3003–3012. 12 indexed citations
18.
Barkauskas, Donald A., Mark Krailo, Sajida Piperdi, et al.. (2014). HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study. Pediatric Blood & Cancer. 61(9). 1558–1564. 17 indexed citations
19.
Gill, Jonathan, et al.. (2011). Operative experience of urological trainees in the UK. British Journal of Urology. 109(9). 1296–1301. 22 indexed citations
20.
Smith, Kevin M., et al.. (2007). Bowel injury at TVT: An issue of consent. Journal of Obstetrics and Gynaecology. 27(7). 741–741. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Mercatali Breakdown of academic impact, for papers by Heribert Juergens Breakdown of academic impact, for papers by François Lamoureux Breakdown of academic impact, for papers by Benjamin Ory Breakdown of academic impact, for papers by Alexander J. Chou Breakdown of academic impact, for papers by Zhenfeng Duan Breakdown of academic impact, for papers by Emiliano Cocco Breakdown of academic impact, for papers by Yuri Sheinin Breakdown of academic impact, for papers by Michael S. Isakoff Breakdown of academic impact, for papers by J.C. Soria
Rankless by CCL
2026